» Articles » PMID: 38650010

Spatial Transcriptomics Reveals Segregation of Tumor Cell States in Glioblastoma and Marked Immunosuppression Within the Perinecrotic Niche

Overview
Publisher Biomed Central
Specialty Neurology
Date 2024 Apr 22
PMID 38650010
Authors
Affiliations
Soon will be listed here.
Abstract

Glioblastoma (GBM) remains an untreatable malignant tumor with poor patient outcomes, characterized by palisading necrosis and microvascular proliferation. While single-cell technology made it possible to characterize different lineage of glioma cells into neural progenitor-like (NPC-like), oligodendrocyte-progenitor-like (OPC-like), astrocyte-like (AC-like) and mesenchymal like (MES-like) states, it does not capture the spatial localization of these tumor cell states. Spatial transcriptomics empowers the study of the spatial organization of different cell types and tumor cell states and allows for the selection of regions of interest to investigate region-specific and cell-type-specific pathways. Here, we obtained paired 10x Chromium single-nuclei RNA-sequencing (snRNA-seq) and 10x Visium spatial transcriptomics data from three GBM patients to interrogate the GBM microenvironment. Integration of the snRNA-seq and spatial transcriptomics data reveals patterns of segregation of tumor cell states. For instance, OPC-like tumor and NPC-like tumor significantly segregate in two of the three samples. Our differentially expressed gene and pathway analyses uncovered significant pathways in functionally relevant niches. Specifically, perinecrotic regions were more immunosuppressive than the endogenous GBM microenvironment, and perivascular regions were more pro-inflammatory. Our gradient analysis suggests that OPC-like tumor cells tend to reside in areas closer to the tumor vasculature compared to tumor necrosis, which may reflect increased oxygen requirements for OPC-like cells. In summary, we characterized the localization of cell types and tumor cell states, the gene expression patterns, and pathways in different niches within the GBM microenvironment. Our results provide further evidence of the segregation of tumor cell states and highlight the immunosuppressive nature of the necrotic and perinecrotic niches in GBM.

Citing Articles

Magnetic resonance diffusion-derived vessel density (DDVD) as a valuable tissue perfusion biomarker for isocitrate dehydrogenase genotyping in diffuse gliomas.

Ni C, Lin R, Yao D, Ma F, Shi Y, He Y BMC Med Imaging. 2025; 25(1):79.

PMID: 40050759 PMC: 11887403. DOI: 10.1186/s12880-025-01605-4.


Transitioning from molecular methods to therapeutic methods: An in‑depth analysis of glioblastoma (Review).

Han H, Du A, Li J, Han H, Feng P, Zhu Y Oncol Rep. 2025; 53(4).

PMID: 40017136 PMC: 11894601. DOI: 10.3892/or.2025.8881.

References
1.
Ren Y, Huang Z, Zhou L, Xiao P, Song J, He P . Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas. Nat Commun. 2023; 14(1):1028. PMC: 9950149. DOI: 10.1038/s41467-023-36707-6. View

2.
Park J, Feroze A, Emerson S, Mihalas A, Keene C, Cimino P . A single-cell based precision medicine approach using glioblastoma patient-specific models. NPJ Precis Oncol. 2022; 6(1):55. PMC: 9360428. DOI: 10.1038/s41698-022-00294-4. View

3.
Liao J, Lu X, Shao X, Zhu L, Fan X . Uncovering an Organ's Molecular Architecture at Single-Cell Resolution by Spatially Resolved Transcriptomics. Trends Biotechnol. 2020; 39(1):43-58. DOI: 10.1016/j.tibtech.2020.05.006. View

4.
Asp M, Bergenstrahle J, Lundeberg J . Spatially Resolved Transcriptomes-Next Generation Tools for Tissue Exploration. Bioessays. 2020; 42(10):e1900221. DOI: 10.1002/bies.201900221. View

5.
Ritchie M, Phipson B, Wu D, Hu Y, Law C, Shi W . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. PMC: 4402510. DOI: 10.1093/nar/gkv007. View